BCL2L1 and neoplasm: Whereas tumor volume gradually increased in the mice treated with 5-FU, similar to vehicle-treated mice, BCLXL inhibitor-treated mice showed stable tumor size as well as a significantly different size compared with vehicle-treated mice (Figs. 7A and B and S2).